#12052 on the rich list of 14,644 insiders
Jay Stout
Chief Technology Officer at Immunovant. Based in Durham, North Carolina.
$6.5M
in disclosed stock, −$95K (−1.45%) today
Live prices, last trade 3:56 PM ET
- Rank
- 12052nd of 14,644
- Companies held
- 1
- Largest holding
- IMVT, 100.0% of total
- Latest SEC filing
- Oct 21, 2026
What the $6.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Immunovant IMVT Common Stock | Directly | 198,937 | $32.69 | $6.5M | 100.0% | Form 4, Oct 21, 2026 |
Share counts are the amounts Jay Stout reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Sold | IMVT | 2,595 | $28.94 | $75K | View |
| Oct 7, 2026 | Sold | IMVT | 2,213 | $32.06 | $71K | View |
| Oct 7, 2026 | Sold | IMVT | 1,596 | $32.06 | $51K | View |
| Jul 23, 2026 | Sold | IMVT | 2,857 | $38.69 | $111K | View |
| Jul 8, 2026 | Sold | IMVT | 1,399 | $39.53 | $55K | View |
| Jul 8, 2026 | Sold | IMVT | 77 | $39.99 | $3K | View |
| Jul 8, 2026 | Sold | IMVT | 105 | $39.99 | $4K | View |
| Jul 8, 2026 | Sold | IMVT | 1,906 | $39.53 | $75K | View |
| Jun 26, 2026 | Sold | IMVT | 6,723 | $38.94 | $262K | View |
| Jun 26, 2026 | Sold | IMVT | 33,277 | $38.18 | $1.3M | View |
| Apr 23, 2026 | Sold | IMVT | 2,754 | $29.62 | $82K | View |
| Apr 8, 2026 | Sold | IMVT | 8,614 | $24.83 | $214K | View |
| Apr 8, 2026 | Sold | IMVT | 1,518 | $24.83 | $38K | View |
| Jan 21, 2026 | Sold | IMVT | 1,977 | $26.03 | $51K | View |
| Jan 7, 2026 | Sold | IMVT | 1,148 | $26.51 | $30K | View |
| Jan 7, 2026 | Sold | IMVT | 55 | $26.92 | $1K | View |
| Oct 22, 2025 | Sold | IMVT | 2,520 | $19.03 | $48K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12049 | Andrew K. Balo EVP Regulatory Strategy Clinic, DexCom. San Diego, CA | $6.5M |
| 12050 | Dennis P. Vermillion Insider, Avista. Spokane, WA | $6.5M |
| 12051 | Kelly E. Garcia EVP, Chief Tech & Data Ofcr, Domino's Pizza. Bolingbrook, IL | $6.5M |
| 12052 | Jay Stout Chief Technology Officer, Immunovant. Durham, NC | $6.5M |
| 12053 | Blake T. DeBerry CEO, Innovex International. Houston, TX | $6.5M |
| 12054 | Gregory John Carven Chief Scientific Officer, Scholar Rock Holding. Cambridge, MA | $6.5M |
| 12055 | Mark Andrew Sherman EVP, Gen. Counsel & Secretary, Dolby Laboratories. San Francisco, CA | $6.5M |
Other Immunovant insiders
All IMVT insiders- Peter Salzmann$38.5MChief Executive Officer. #3094 overall
- Frank Torti$33.0MDirector. #475 overall
- Julia G. Butchko$14.4MChief Development Officer. #6660 overall
- Eva Renee Barnett$13.0MChief Financial Officer. #7228 overall
- William L. Macias$11.7MChief Medical Officer. #7834 overall
- Mark S. Levine$10.4MChief Legal Officer. #8522 overall
Questions
How much stock does Jay Stout own?
Jay Stout holds $6,503,251 in listed stock based on SEC filings and current prices, mostly Immunovant (IMVT). That ranks 12052nd on the Stock Rich List.
Is this Jay Stout's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jay Stout last buy or sell stock?
The most recent open-market trade on file is a sale of 2,595 IMVT shares on Oct 21, 2026 at $28.94.